Key Ingredients
Darifenacin (7.5 mg – Prolonged Release): A highly selective M3-muscarinic receptor antagonist that relaxes the detrusor muscle of the bladder, offering targeted OAB symptom control with excellent long-term safety.
Benefits
Highest M3 Selectivity: Provides targeted bladder relaxation while minimizing unwanted side effects such as blurred vision or rapid heartbeat seen with non-selective antimuscarinics.
Once-Daily Prolonged Release: The advanced OD (Once Daily) matrix offers sustained Darifenacin release, allowing 24-hour symptom control and improved adherence.
Clinically Proven Long-Term Safety: Suitable for patients requiring chronic OAB management, with an established safety and efficacy profile.
Improves Quality of Life: Enhances bladder capacity, sleep quality, mobility confidence, and day-to-day comfort.
Usage Instructions
- Take one DEYTEN OD 7.5 tablet daily, or as prescribed.
- Swallow whole; do not crush or split, as this interferes with the prolonged-release mechanism.
- Regular daily use results in the best symptom improvement.
Side Effects
May include dry mouth, constipation, blurred vision, headache, or mild abdominal discomfort.
Seek advice from a healthcare professional if symptoms persist.
General Information
- Brand Name: DEYTEN OD 7.5
- Strength: Darifenacin 7.5 mg (Prolonged Release)
- Form: Tablet
- Packaging Size: 10×10 Tablets
- Packaging Type: Box
- Manufacturer: Globus Labs
- Category: Overactive Bladder Treatment
- Country of Origin: India
Globus Labs brings you WHO-GMP–certified, high-quality Darifenacin 7.5 mg sourced from reputed pharmaceutical manufacturers. DEYTEN OD 7.5 is formulated to deliver safe, potent, and clinically trusted support.
